Urinary biomarkers for lung cancer detection

Area of Science:

• Biochemistry
• Molecular Biology
• Genomics

Background:

• Current healthcare relies on passive disease detection, often identifying illnesses when irreversible damage has occurred.
• Degenerative diseases begin at the cellular level, necessitating proactive monitoring for early intervention.
• Organ-specific nucleic acids, like microRNAs (miRs), regulate tissue function and can indicate health status.

Purpose of the Study:

• To investigate the feasibility of non-invasive health monitoring using urinary small RNAs.
• To establish a proactive approach for early disease detection through accessible biomarkers.
• To demonstrate the detection of organ-specific signals in urine, even from non-adjacent organs.

Main Methods:

• Utilized next-generation sequencing (NGS) for comprehensive analysis of small RNA profiles.
• Analyzed urinary samples from healthy donors and drug-naïve lung cancer patients.
• Focused on computational analysis of large datasets to extract reliable longitudinal information.

Main Results:

• Identified specific urinary biomarkers, including small RNAs, in healthy and lung cancer patient samples.
• Confirmed that small RNAs can effectively pass through the kidney filtration system.
• Demonstrated the presence of organ-specific small RNA signatures in urine.

Conclusions:

• Non-invasive health monitoring via sequencing of urinary small RNAs is a viable proof-of-principle.
• Early detection of neoplastic transformation, even from organs like the lungs, is achievable through urine analysis.
• This approach offers a promising avenue for proactive healthcare and early disease intervention.